66:
176:
25:
303:
379:
Another important role for RELIS is pharmacovigilance. RELIS receives adverse side effect alerts submitted by health professionals, and RELIS then judges the course and causalities of each case, and sends a written reply to the person who submitted the message. The adverse side effect reports are
337:. RELIS was established to aid rational and proper medicines use through producer-independent drug information to health professionals. RELIS started its service at two centres in 1995, and has since 2001 been established at
186:
345:
departments at the university hospitals. RELIS has a question-answer service which aids health professionals in matters of medical drugs, often specific to an individual
424:
376:('Safe Mommy Medicine'). This service is accessible through its own website, and also by phone. It is open to the public and is confidential and free of charge.
200:
of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be
434:
429:
385:
289:
271:
157:
52:
252:
138:
95:
224:
110:
91:
231:
197:
117:
419:
381:
238:
193:
124:
372:
RELIS is also responsible for an information service aided at pregnant and breastfeeding women called
209:
76:
220:
106:
80:
87:
38:
342:
380:
then registered in a national adverse side effect database, in close cooperation with the
8:
338:
330:
373:
314:
205:
201:
245:
131:
350:
406:- RELIS' information service for pregnant and breast feeding women (Norwegian)
413:
326:
354:
44:
341:
in all four health regions of Norway. All the centres are tied to the
65:
366:
358:
346:
192:
Please help to demonstrate the notability of the topic by citing
334:
322:
362:
349:. The target group and users of the service is primarily
302:
400:- RELIS' home page for health professionals (Norwegian)
403:
397:
425:Medical and health organisations based in Norway
411:
187:notability guidelines for products and services
311:Regional Medicines Information Centres (RELIS)
16:Norwegian public medical information service
94:. Unsourced material may be challenged and
53:Learn how and when to remove these messages
290:Learn how and when to remove this message
272:Learn how and when to remove this message
158:Learn how and when to remove this message
301:
412:
319:Regionale legemiddelinformasjonssentre
386:Ministry of Health and Care Services
169:
92:adding citations to reliable sources
59:
18:
13:
14:
446:
391:
325:funded information service about
34:This article has multiple issues.
174:
64:
23:
42:or discuss these issues on the
1:
435:1995 establishments in Norway
430:Government agencies of Norway
7:
384:. RELIS is financed by the
10:
451:
382:Norwegian Medicines Agency
194:reliable secondary sources
183:The topic of this article
185:may not meet Knowledge's
404:www.tryggmammamedisin.no
318:
307:
343:clinical pharmacology
305:
339:university hospitals
331:health professionals
88:improve this article
420:Pharmacy in Norway
374:Trygg Mammamedisin
308:
189:
369:use the service.
300:
299:
292:
282:
281:
274:
256:
184:
168:
167:
160:
142:
57:
442:
295:
288:
277:
270:
266:
263:
257:
255:
214:
178:
177:
170:
163:
156:
152:
149:
143:
141:
100:
68:
60:
49:
27:
26:
19:
450:
449:
445:
444:
443:
441:
440:
439:
410:
409:
394:
351:medical doctors
296:
285:
284:
283:
278:
267:
261:
258:
215:
213:
191:
179:
175:
164:
153:
147:
144:
101:
99:
85:
69:
28:
24:
17:
12:
11:
5:
448:
438:
437:
432:
427:
422:
408:
407:
401:
393:
392:External links
390:
306:The RELIS logo
298:
297:
280:
279:
182:
180:
173:
166:
165:
72:
70:
63:
58:
32:
31:
29:
22:
15:
9:
6:
4:
3:
2:
447:
436:
433:
431:
428:
426:
423:
421:
418:
417:
415:
405:
402:
399:
396:
395:
389:
387:
383:
377:
375:
370:
368:
364:
360:
356:
352:
348:
344:
340:
336:
332:
328:
327:medical drugs
324:
320:
316:
312:
304:
294:
291:
276:
273:
265:
262:February 2018
254:
251:
247:
244:
240:
237:
233:
230:
226:
223: –
222:
218:
217:Find sources:
211:
207:
203:
199:
195:
188:
181:
172:
171:
162:
159:
151:
148:February 2018
140:
137:
133:
130:
126:
123:
119:
116:
112:
109: –
108:
104:
103:Find sources:
97:
93:
89:
83:
82:
78:
73:This article
71:
67:
62:
61:
56:
54:
47:
46:
41:
40:
35:
30:
21:
20:
398:www.relis.no
378:
371:
310:
309:
286:
268:
259:
249:
242:
235:
228:
216:
154:
145:
135:
128:
121:
114:
102:
86:Please help
74:
50:
43:
37:
36:Please help
33:
355:pharmacists
353:, but also
198:independent
414:Categories
232:newspapers
206:redirected
118:newspapers
39:improve it
315:Norwegian
196:that are
75:does not
45:talk page
367:midwives
359:dentists
323:publicly
347:patient
321:) is a
246:scholar
221:"RELIS"
210:deleted
132:scholar
107:"RELIS"
96:removed
81:sources
363:nurses
335:Norway
248:
241:
234:
227:
219:
202:merged
134:
127:
120:
113:
105:
253:JSTOR
239:books
208:, or
139:JSTOR
125:books
365:and
329:for
225:news
111:news
79:any
77:cite
333:in
90:by
416::
388:.
361:,
357:,
317::
204:,
48:.
313:(
293:)
287:(
275:)
269:(
264:)
260:(
250:·
243:·
236:·
229:·
212:.
190:.
161:)
155:(
150:)
146:(
136:·
129:·
122:·
115:·
98:.
84:.
55:)
51:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
